{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T23:18:19Z","timestamp":1791242299969,"version":"4.1.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2017,3,8]],"date-time":"2017-03-08T00:00:00Z","timestamp":1488931200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006209","name":"Radboud University Medical Center","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006209","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s11606-017-4000-7","type":"journal-article","created":{"date-parts":[[2017,3,8]],"date-time":"2017-03-08T14:55:30Z","timestamp":1488984930000},"page":"921-930","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["A Network Meta-Analysis of Clinical Management Strategies for Treatment-Resistant Hypertension: Making Optimal Use of the Evidence"],"prefix":"10.1007","volume":"32","author":[{"given":"Peter","family":"Makai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"IntHout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaap","family":"Deinum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Jenniskens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert Jan van der","family":"Wilt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,8]]},"reference":[{"issue":"5","key":"4000_CR1","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","volume":"311","author":"PA James","year":"2014","unstructured":"James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507\u201320.","journal-title":"JAMA"},{"issue":"9","key":"4000_CR2","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/jama.2013.184182","volume":"310","author":"CK Chow","year":"2013","unstructured":"Chow CK, Teo KK, Rangarajan S, Islam S, Gupta R, Avezum A, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA. 2013;310(9):959\u201368.","journal-title":"JAMA"},{"key":"4000_CR3","unstructured":"Organization WH. Global health risks: mortality and burden of disease attributable to selected major risks: World Health Organization; 2009"},{"issue":"4","key":"4000_CR4","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3109\/08037051.2013.812549","volume":"22","author":"G Mancia","year":"2013","unstructured":"Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, B\u00f6hm M, et al. 2013 ESH\/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Blood Press. 2013;22(4):193\u2013278.","journal-title":"Blood Press"},{"key":"4000_CR5","doi-asserted-by":"crossref","unstructured":"Achelrod D, Wenzel U, Frey S. Systematic review and meta-analysis of the prevalence of resistant hypertension in treated hypertensive populations. Am J Hypertens. 2014:hpu151","DOI":"10.1093\/ajh\/hpu151"},{"issue":"22","key":"4000_CR6","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","volume":"373","author":"JT Wright","year":"2015","unstructured":"Wright JT, Williamson JD, Whelton PK, Snyder JK, Sink KM, Rocco MV, et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373(22):2103\u201316.","journal-title":"N Engl J Med"},{"issue":"22","key":"4000_CR7","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMp1513290","volume":"373","author":"AV Chobanian","year":"2015","unstructured":"Chobanian AV. Time to Reassess Blood-Pressure Goals. N Engl J Med. 2015;373(22):2093\u20135.","journal-title":"N Engl J Med"},{"key":"4000_CR8","unstructured":"Bress AP, Tanner RM, Hess R, Colantonio LD, Shimbo D, Muntner P. Generalizability of results from the Systolic Blood Pressure Intervention Trial (SPRINT) to the US adult population. J Am Coll Cardio. 2015."},{"issue":"22","key":"4000_CR9","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1056\/NEJMe1513301","volume":"373","author":"V Perkovic","year":"2015","unstructured":"Perkovic V, Rodgers A. Redefining blood-pressure targets\u2014SPRINT starts the marathon. N Engl J Med. 2015;373(22):2175\u20138.","journal-title":"N Engl J Med"},{"issue":"6","key":"4000_CR10","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1161\/HYPERTENSIONAHA.108.189141","volume":"51","author":"DA Calhoun","year":"2008","unstructured":"Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, et al. Resistant hypertension: diagnosis, evaluation, and treatment a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension. 2008;51(6):1403\u201319.","journal-title":"Hypertension"},{"issue":"4","key":"4000_CR11","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/HJH.0b013e32835e2286","volume":"31","author":"O Jung","year":"2013","unstructured":"Jung O, Gechter JL, Wunder C, Paulke A, Bartel C, Geiger H, et al. Resistant hypertension? Assessment of adherence by toxicological urine analysis. J Hypertens. 2013;31(4):766\u201374.","journal-title":"J Hypertens"},{"issue":"12","key":"4000_CR12","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1161\/CIRCULATIONAHA.116.022922","volume":"134","author":"M Azizi","year":"2016","unstructured":"Azizi M, Pereira H, Hamdidouche I, Gosse P, Monge M, Bobrie G, et al. Adherence to Antihypertensive Treatment and the Blood Pressure-Lowering Effects of Renal Denervation in the Renal Denervation for Hypertension (DENERHTN) Trial. Circulation. 2016;134(12):847\u201357.","journal-title":"Circulation"},{"issue":"8","key":"4000_CR13","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.jacc.2013.10.067","volume":"63","author":"S Brinker","year":"2014","unstructured":"Brinker S, Pandey A, Ayers C, Price A, Raheja P, Arbique D, et al. Therapeutic drug monitoring facilitates blood pressure control in resistant hypertension. J Am Coll Cardiol. 2014;63(8):834\u20135.","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"4000_CR14","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1001\/jama.2014.5180","volume":"311","author":"W Vongpatanasin","year":"2014","unstructured":"Vongpatanasin W. Resistant hypertension: a review of diagnosis and management. JAMA. 2014;311(21):2216\u201324.","journal-title":"JAMA"},{"issue":"10","key":"4000_CR15","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1524-6175.2007.07244.x","volume":"9","author":"HR Black","year":"2007","unstructured":"Black HR, Bakris GL, Weber MA, Weiss R, Shahawy ME, Marple R, et al. Efficacy and Safety of Darusentan in Patients With Resistant Hypertension: Results From a Randomized, Double\u2010Blind, Placebo\u2010Controlled Dose\u2010Ranging Study. Am J Clin Hypn. 2007;9(10):760\u20139.","journal-title":"Am J Clin Hypn"},{"issue":"9978","key":"4000_CR16","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/S0140-6736(14)62053-5","volume":"385","author":"MD Lobo","year":"2015","unstructured":"Lobo MD, Sobotka PA, Stanton A, Cockcroft JR, Sulke N, Dolan E, et al. Central arteriovenous anastomosis for the treatment of patients with uncontrolled hypertension (the ROX CONTROL HTN study): a randomised controlled trial. Lancet. 2015;385(9978):1634\u201341.","journal-title":"Lancet"},{"issue":"6","key":"4000_CR17","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.amjcard.2014.06.018","volume":"114","author":"SB Pancholy","year":"2014","unstructured":"Pancholy SB, Shantha GPS, Patel TM, Sobotka PA, Kandzari DE. Meta-analysis of the effect of renal denervation on blood pressure and pulse pressure in patients with resistant systemic hypertension. Am J Cardiol. 2014;114(6):856\u201361.","journal-title":"Am J Cardiol"},{"issue":"15","key":"4000_CR18","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1056\/NEJMoa1402670","volume":"370","author":"DL Bhatt","year":"2014","unstructured":"Bhatt DL, Kandzari DE, O\u2019Neill WW, D\u2019Agostino R, Flack JM, Katzen BT, et al. A controlled trial of renal denervation for resistant hypertension. N Engl J Med. 2014;370(15):1393\u2013401.","journal-title":"N Engl J Med"},{"key":"4000_CR19","doi-asserted-by":"crossref","unstructured":"Azizi M, Sapoval M, Gosse P, Monge M, Bobrie G, Delsart P, et al. Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial. Lancet. 2015","DOI":"10.1016\/S0140-6736(14)61942-5"},{"key":"4000_CR20","unstructured":"Rosa J, Widimsk\u00fd P, Tou\u0161ek P, Petr\u00e1k O, \u010curila K, Waldauf P, et al. Randomized Comparison of Renal Denervation Versus Intensified Pharmacotherapy Including Spironolactone in True-Resistant Hypertension Six-Month Results From the Prague-15 Study. Hypertension. 2014:HYPERTENSIONAHA. 114.04019"},{"issue":"1","key":"4000_CR21","doi-asserted-by":"crossref","first-page":"e000092","DOI":"10.1136\/openhrt-2014-000092","volume":"1","author":"CS Kwok","year":"2014","unstructured":"Kwok CS, Loke YK, Pradhan S, Keavney B, El-Omar M, Mamas MA. Renal denervation and blood pressure reduction in resistant hypertension: a systematic review and meta-analysis. Open Heart. 2014;1(1):e000092.","journal-title":"Open Heart"},{"key":"4000_CR22","doi-asserted-by":"crossref","unstructured":"Zhang X, Wu N, Yan W, Zhou C, Guo H. The effects of renal denervation on resistant hypertension patients: a meta-analysis. Blood pressure monitoring. 2016","DOI":"10.1097\/MBP.0000000000000177"},{"key":"4000_CR23","unstructured":"Elmula FEMF, Jin Y, Yang W-Y, Thijs L, Lu Y-C, Larstorp AC, et al. Meta-analysis of randomized controlled trials of renal denervation in treatment-resistant hypertension. Blood press. 2015(ahead-of-print):1\u201312"},{"issue":"2","key":"4000_CR24","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jval.2014.01.004","volume":"17","author":"JP Jansen","year":"2014","unstructured":"Jansen JP, Trikalinos T, Cappelleri JC, Daw J, Andes S, Eldessouki R, et al. Indirect treatment comparison\/network meta-analysis study questionnaire to assess relevance and credibility to inform health care decision making: an ISPOR-AMCP-NPC Good Practice Task Force report. Value Health. 2014;17(2):157\u201373.","journal-title":"Value Health"},{"issue":"2","key":"4000_CR25","doi-asserted-by":"crossref","first-page":"130","DOI":"10.7326\/0003-4819-159-2-201307160-00008","volume":"159","author":"A Cipriani","year":"2013","unstructured":"Cipriani A, Higgins JP, Geddes JR, Salanti G. Conceptual and technical challenges in network meta-analysis. Ann Intern Med. 2013;159(2):130\u20137.","journal-title":"Ann Intern Med"},{"issue":"1","key":"4000_CR26","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/jch.12237","volume":"16","author":"MA Weber","year":"2014","unstructured":"Weber MA, Schiffrin EL, White WB, Mann S, Lindholm LH, Kenerson JG, et al. Clinical practice guidelines for the management of hypertension in the community. J Clin Hypertens. 2014;16(1):14\u201326.","journal-title":"J Clin Hypertens"},{"key":"4000_CR27","unstructured":"Makai P, intHout J, Grutters JPC, Deinum J, Jenniskens K, Van der Wilt GJ. Network meta-analysis of various strategies in treatment resistant hypertension. 2017. http:\/\/www.crd.york.ac.uk\/PROSPERO\/display_record.asp?ID=CRD42015017323"},{"key":"4000_CR28","doi-asserted-by":"crossref","unstructured":"Liu G, Zheng X, Xu Y, Lu J, Hui R, Huang X. Effect of aldosterone antagonists on blood pressure in patients with resistant hypertension: a meta-analysis. J Hum Hypertens. 2014","DOI":"10.1038\/jhh.2014.64"},{"issue":"5","key":"4000_CR29","first-page":"7270","volume":"8","author":"H Guo","year":"2015","unstructured":"Guo H, Xiao Q. Clinical efficacy of spironolactone for resistant hypertension: a meta analysis from randomized controlled clinical trials. Int J Clin Exp Med. 2015;8(5):7270.","journal-title":"Int J Clin Exp Med"},{"issue":"2","key":"4000_CR30","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1161\/HYPERTENSIONAHA.114.04640","volume":"65","author":"HC Patel","year":"2015","unstructured":"Patel HC, Hayward C, Ozdemir BA, Rosen SD, Krum H, Lyon AR, et al. Magnitude of Blood Pressure Reduction in the Placebo Arms of Modern Hypertension Trials Implications for Trials of Renal Denervation. Hypertension. 2015;65(2):401\u20136.","journal-title":"Hypertension"},{"key":"4000_CR31","doi-asserted-by":"crossref","unstructured":"Higgins JP, Altman DG, G\u00f8tzsche PC, J\u00fcni P, Moher D, Oxman AD, et al. The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ. 2011;343","DOI":"10.1136\/bmj.d5928"},{"issue":"7650","key":"4000_CR32","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924\u20136.","journal-title":"BMJ"},{"issue":"15","key":"4000_CR33","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1001\/jama.288.15.1882","volume":"288","author":"PK Whelton","year":"2002","unstructured":"Whelton PK, He J, Appel LJ, Cutler JA, Havas S, Kotchen TA, et al. Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program. JAMA. 2002;288(15):1882\u20138.","journal-title":"JAMA"},{"key":"4000_CR34","unstructured":"Team RC. R: A language and environment for statistical computing. In: R Foundation for Statistical Computing. Vienna, Austria. 2017. http:\/\/www.R-project.org\/accessed 01.09.2017"},{"key":"4000_CR35","unstructured":"Gert van Valkenhoef JK. gemtc. 2017. http:\/\/github.com\/gertvv\/gemtc accessed 01.09.2017"},{"issue":"4","key":"4000_CR36","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/jrsm.1054","volume":"3","author":"G Valkenhoef","year":"2012","unstructured":"Valkenhoef G, Lu G, Brock B, Hillege H, Ades A, Welton NJ. Automating network meta-analysis. Res Synth Meth. 2012;3(4):285\u201399.","journal-title":"Res Synth Meth"},{"key":"4000_CR37","unstructured":"DeMaggio C. Bayesian Analysis for Epidemiologists Part IV: Meta-Analysis. 2017. http:\/\/www.columbia.edu\/\u223ccjd11\/charles_dimaggio\/DIRE\/styled-4\/styled-11\/code-9\/accessed 01.09.2017"},{"key":"4000_CR38","unstructured":"Spineli L, Mairgiotis A, Salanti G. Plot of a treatment comparisons network in R. 2013. http:\/\/www.mtm.uoi.gr\/index.php\/how-to-do-an-mtm\/10-how-to-do-an-mtm\/15-graphicaldescriptionofanetwork . accessed 01.09.2017"},{"key":"4000_CR39","doi-asserted-by":"crossref","unstructured":"Valkenhoef G, Dias S, Ades A, Welton NJ. Automated generation of node-splitting models for assessment of inconsistency in network meta-analysis. Res Synth Meth. 2015","DOI":"10.1002\/jrsm.1167"},{"issue":"11","key":"4000_CR40","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","volume":"162","author":"B Hutton","year":"2015","unstructured":"Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, Cameron C, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. 2015;162(11):777\u201384.","journal-title":"Ann Intern Med"},{"issue":"4","key":"4000_CR41","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","volume":"151","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264\u20139.","journal-title":"Ann Intern Med"},{"issue":"5","key":"4000_CR42","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1001\/jamainternmed.2015.0237","volume":"175","author":"LA Beveridge","year":"2015","unstructured":"Beveridge LA, Struthers AD, Khan F, Jorde R, Scragg R, Macdonald HM, et al. Effect of vitamin D supplementation on blood pressure: a systematic review and meta-analysis incorporating individual patient data. JAMA Intern Med. 2015;175(5):745\u201354.","journal-title":"JAMA Intern Med"},{"issue":"9756","key":"4000_CR43","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(10)62039-9","volume":"376","author":"SH Investigators","year":"2010","unstructured":"Investigators SH. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet. 2010;376(9756):1903\u20139.","journal-title":"Lancet"},{"issue":"6","key":"4000_CR44","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1253\/circj.CJ-15-0150","volume":"79","author":"K Kario","year":"2015","unstructured":"Kario K, Ogawa H, Okumura K, Okura T, Saito S, Ueno T, et al. SYMPLICITY HTN-Japan\u2014First Randomized Controlled Trial of Catheter-Based Renal Denervation in Asian Patients. Circ J. 2015;79(6):1222\u20139.","journal-title":"Circ J"},{"issue":"6","key":"4000_CR45","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1161\/HYPERTENSIONAHA.115.05283","volume":"65","author":"S Desch","year":"2015","unstructured":"Desch S, Okon T, Heinemann D, Kulle K, R\u00f6hnert K, Sonnabend M, et al. Randomized sham-controlled trial of renal sympathetic denervation in mild resistant hypertension. Hypertension. 2015;65(6):1202\u20138.","journal-title":"Hypertension"},{"key":"4000_CR46","doi-asserted-by":"crossref","unstructured":"Mathiassen ON, Vase H, Bech JN, Christensen KL, Buus NH, Schroeder AP, et al. Renal denervation in treatment-resistant essential hypertension. A randomized, SHAM-controlled, double-blinded 24-h blood pressure-based trial. J Hypertens. 2016;34:000","DOI":"10.1097\/HJH.0000000000000977"},{"issue":"9","key":"4000_CR47","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1097\/HJH.0000000000001025","volume":"34","author":"A Oliveras","year":"2016","unstructured":"Oliveras A, Armario P, Clar\u00e0 A, Sans-Atxer L, V\u00e1zquez S, Pascual J, et al. Spironolactone versus sympathetic renal denervation to treat true resistant hypertension: results from the DENERVHTA study\u2014a randomized controlled trial. J Hypertens. 2016;34(9):1863.","journal-title":"J Hypertens"},{"issue":"27","key":"4000_CR48","doi-asserted-by":"crossref","first-page":"e162","DOI":"10.1097\/MD.0000000000000162","volume":"93","author":"J V\u00e1clav\u00edk","year":"2014","unstructured":"V\u00e1clav\u00edk J, Sedl\u00e1k R, Jarkovsk\u00fd J, Koci\u00e1nov\u00e1 E, T\u00e1borsk\u00fd M. Effect of spironolactone in resistant arterial hypertension: a randomized, double-blind, placebo-controlled trial (ASPIRANT-EXT). Medicine. 2014;93(27):e162.","journal-title":"Medicine"},{"issue":"10","key":"4000_CR49","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1097\/HJH.0b013e3283638b1a","volume":"31","author":"CS Oxlund","year":"2013","unstructured":"Oxlund CS, Henriksen JE, Tarnow L, Schousboe K, Gram J, Jacobsen IA. Low dose spironolactone reduces blood pressure in patients with resistant hypertension and type 2 diabetes mellitus: a double blind randomized clinical trial. J Hypertens. 2013;31(10):2094\u2013102.","journal-title":"J Hypertens"},{"issue":"9","key":"4000_CR50","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/jch.12374","volume":"16","author":"X Ni","year":"2014","unstructured":"Ni X, Zhang J, Zhang P, Wu F, Xia M, Ying G, et al. Effects of spironolactone on dialysis patients with refractory hypertension: a randomized controlled study. J Clin Hypertens. 2014;16(9):658\u201363.","journal-title":"J Clin Hypertens"},{"issue":"8","key":"4000_CR51","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1097\/HJH.0b013e3283551e98","volume":"30","author":"G Bobrie","year":"2012","unstructured":"Bobrie G, Frank M, Azizi M, Peyrard S, Boutouyrie P, Chatellier G, et al. Sequential nephron blockade versus sequential renin\u2013angiotensin system blockade in resistant hypertension: a prospective, randomized, open blinded endpoint study. J Hypertens. 2012;30(8):1656\u201364.","journal-title":"J Hypertens"},{"issue":"5","key":"4000_CR52","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3109\/10641963.2015.1131290","volume":"38","author":"L Yang","year":"2016","unstructured":"Yang L, Zhang H, Cai M, Zou Y, Jiang X, Song L, et al. Effect of spironolactone on patients with resistant hypertension and obstructive sleep apnea. Clin Exp Hypertens. 2016;38(5):464\u20138.","journal-title":"Clin Exp Hypertens"},{"issue":"5","key":"4000_CR53","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1161\/HYPERTENSIONAHA.110.156976","volume":"56","author":"GL Bakris","year":"2010","unstructured":"Bakris GL, Lindholm LH, Black HR, Krum H, Linas S, Linseman JV, et al. Divergent results using clinic and ambulatory blood pressures report of a darusentan-resistant hypertension trial. Hypertension. 2010;56(5):824\u201330.","journal-title":"Hypertension"},{"issue":"9699","key":"4000_CR54","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/S0140-6736(09)61500-2","volume":"374","author":"MA Weber","year":"2009","unstructured":"Weber MA, Black H, Bakris G, Krum H, Linas S, Weiss R, et al. A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial. Lancet. 2009;374(9699):1423\u201331.","journal-title":"Lancet"},{"issue":"3","key":"4000_CR55","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/jch.12051","volume":"15","author":"AD Karns","year":"2013","unstructured":"Karns AD, Bral JM, Hartman D, Peppard T, Schumacher C. Study of Aldosterone Synthase Inhibition as an Add\u2010On Therapy in Resistant Hypertension. J Clin Hypertens. 2013;15(3):186\u201392.","journal-title":"J Clin Hypertens"},{"key":"4000_CR56","doi-asserted-by":"crossref","unstructured":"Eguchi K, Kabutoya T, Hoshide S, Ishikawa S, Kario K. Add-On Use of Eplerenone Is Effective for Lowering Home and Ambulatory Blood Pressure in Drug-Resistant Hypertension. J Clin Hypertens. 2016","DOI":"10.1111\/jch.12860"},{"issue":"10008","key":"4000_CR57","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(15)00257-3","volume":"386","author":"B Williams","year":"2015","unstructured":"Williams B, MacDonald TM, Morant S, Webb DJ, Sever P, McInnes G, et al. Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial. Lancet. 2015;386(10008):2059\u201368.","journal-title":"Lancet"},{"key":"4000_CR58","doi-asserted-by":"crossref","unstructured":"Dahal K, Kunwar S, Rijal J, Alqatahni F, Panta R, Ishak N, et al. The Effects of Aldosterone Antagonists in Patients With Resistant Hypertension: A Meta-Analysis of Randomized and Nonrandomized Studies. Am J Hypertens. 2015:hpv031","DOI":"10.1093\/ajh\/hpv031"},{"issue":"7538","key":"4000_CR59","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1136\/bmj.38726.603310.55","volume":"332","author":"TJ Kaptchuk","year":"2006","unstructured":"Kaptchuk TJ, Stason WB, Davis RB, Legedza AR, Schnyer RN, Kerr CE, et al. Sham device v inert pill: randomised controlled trial of two placebo treatments. BMJ. 2006;332(7538):391\u20137.","journal-title":"BMJ"},{"issue":"7","key":"4000_CR60","doi-asserted-by":"crossref","first-page":"e67485","DOI":"10.1371\/journal.pone.0067485","volume":"8","author":"J Kong","year":"2013","unstructured":"Kong J, Spaeth R, Cook A, Kirsch I, Claggett B, Vangel M, et al. Are all placebo effects equal? Placebo pills, sham acupuncture, cue conditioning and their association. PLoS ONE. 2013;8(7):e67485.","journal-title":"PLoS ONE"},{"issue":"9715","key":"4000_CR61","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S0140-6736(09)61706-2","volume":"375","author":"DG Finniss","year":"2010","unstructured":"Finniss DG, Kaptchuk TJ, Miller F, Benedetti F. Biological, clinical, and ethical advances of placebo effects. Lancet. 2010;375(9715):686\u201395.","journal-title":"Lancet"},{"key":"4000_CR62","doi-asserted-by":"crossref","unstructured":"Pandey A, Raza F, Velasco A, Brinker S, Ayers C, Das SR, et al. Comparison of Morisky Medication Adherence Scale with therapeutic drug monitoring in apparent treatment-resistant hypertension. J Am Soc Hypertens. 2015;9(6):420\u20136.e2","DOI":"10.1016\/j.jash.2015.04.004"}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11606-017-4000-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-017-4000-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-017-4000-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T09:37:08Z","timestamp":1568885828000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11606-017-4000-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,8]]},"references-count":62,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["4000"],"URL":"https:\/\/doi.org\/10.1007\/s11606-017-4000-7","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,8]]}}}